Drawing for VITALRX

USPTO serial 86783607

VITALRX

Reviewed by CopyMark Law Group

Reg. 5014629Status 701Renewal
Filing date
Status date
Registration date
Aug 2, 2016
Examiner
WILSON, MARYNELLE WEST
Law office
TMO LAW OFFICE 113

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 701: Status 701 means the registration is active and the first Section 8 declaration of continued use was accepted. The next major deadline is the combined Section 8 and Section 9 filing at the 10-year anniversary.

Need help with VITALRX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $399*

Plus Government fees of $850

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

MICHAEL J DOUGLAS

MICHAEL J DOUGLAS Leak & Douglas P C17 20th St N Ste 200Birmingham, AL 35203-4027UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
035Mail order pharmacy services; Retail pharmacy servicesACTIVEMay 1, 2016

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 2, 2025REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED—
Jan 12, 2022NAS8NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED—
Jan 12, 20228.OKREGISTERED - SEC. 8 (6-YR) ACCEPTEDThe USPTO accepted your Section 8 declaration showing the mark is still in use in commerce (or excusable nonuse). This satisfies the six-year maintenance requirement and keeps the registration active until the next renewal deadline.
Jan 12, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Aug 4, 2021ES8RTEAS SECTION 8 RECEIVED—
Aug 2, 2021REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Aug 2, 2016R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Jul 1, 2016SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Jun 30, 2016CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Jun 27, 2016SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Jun 27, 2016AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Jun 3, 2016IUAFUSE AMENDMENT FILED—
Jun 3, 2016EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
May 10, 2016NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Mar 15, 2016NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Mar 15, 2016PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Feb 24, 2016NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Feb 3, 2016CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Feb 1, 2016DOCKASSIGNED TO EXAMINER—
Oct 16, 2015MPMKNOTICE OF PSEUDO MARK E-MAILED—
Oct 15, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 13, 2015NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance